- This study presents the results of a joint analysis of patterns of consumption, expenditure, and unit expenditure for a core set of drugs aimed at preventing and treating cardiovascular disease. The current study examines the relationships among three pharmaceutical variables (expenditure, volume of drug use, and unit expenditure) classified according to eight therapeutic categories which are specific for the prevention and treatment of cardiovascular disease and stroke. It covers an 11-year time period, and specifies relevant country-specific structural features in a sample of 12 OECD countries.
- The data presented in this report show how the three descriptive pharmaceutical variables vary across these countries. The study also contains a preliminary exploration of factors associated with variation in these variables across countries and through time. Findings for each of the eight cardiovascular disease and stroke drug therapeutic categories investigated in this study are ...
Pharmaceutical Use and Expenditure for Cardiovascular Disease and Stroke
A Study of 12 OECD Countries
Working paper
Share
Facebook
Twitter
LinkedIn
Abstract
In the same series
-
10 April 202641 Pages
-
Working paper
Balancing resilience and sustainability in challenging times
31 March 202634 Pages -
Working paper
Lessons for Slovenia
22 January 202672 Pages -
Working paper16 January 202699 Pages
-
Working paper
An analysis of emergency department visits and hospitalisation data from 16 countries
17 December 202555 Pages -
Working paper
New indicators for benchmarking performance
10 December 202572 Pages -
Working paper
Insights into structures and solutions for public access and use
8 December 202557 Pages
Related publications
-
Policy brief
Insights from the Patient‑Reported Indicator Surveys (PaRIS)
25 March 202611 Pages -
13 December 201978 Pages
-
17 June 2015180 Pages
-
17 June 20158 Pages
-
Working paper28 October 200452 Pages
-
Working paper22 April 2003123 Pages